InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the detailed record of transactions filed by Karpf David B, Directeur Médical. Insider active across 2 companies, notably LUMOS PHARMA, INC.. Cumulatively, 3 filings have been published. Activity tracked since 1 February 2022. The latest transaction was disclosed on 1 February 2023 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations
David B. Karpf is the Chief Medical Officer at Lumos Pharma, Inc. He oversees the company's medical and clinical initiatives, ensuring innovation and efficacy in treatments. David B. Karpf plays a key role in the medical direction of the company, contributing to its success in the biotechnology field.